Javascript must be enabled to continue!
Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
View through CrossRef
Objective
Subsequent protection from SARS-CoV-2 infection in paediatrics is not well reported in the literature. We aimed to describe the clinical characteristics and dynamics of SARS-CoV-2 PCR repositivity in children.
Design
This is a population-level retrospective cohort study.
Setting
Patients were identified through multiple national-level electronic COVID-19 databases that cover all primary, secondary and tertiary centres in Kuwait.
Participants
The study included children 12 years and younger between 28 February 2020 and 6 March 2021. SARS-CoV-2 reinfection was defined as having two or more positive SARS-CoV-2 PCR tests done on a respiratory sample, at least 45 days apart. Clinical data were obtained from the Pediatric COVID-19 Registry in Kuwait.
Primary and secondary outcome measures
The primary measure is to estimate SARS-CoV-2 PCR repositivity rate. The secondary objective was to establish average duration between first and subsequent SARS-CoV-2 infection. Descriptive statistics were used to present clinical data for each infection episode. Also, incidence-sensitivity analysis was performed to evaluate 60-day and 90-day PCR repositivity intervals.
Results
Thirty paediatric patients with COVID-19 had SARS-CoV-2 reinfection at an incidence of 1.02 (95% CI 0.71 to 1.45) infection per 100 000 person-days and a median time to reinfection of 83 (IQR 62–128.75) days. The incidence of reinfection decreased to 0.78 (95% CI 0.52 to 1.17) and 0.47 (95% CI 0.28 to 0.79) per person-day when the minimum interval between PCR repositivity was increased to 60 and 90 days, respectively. The mean age of reinfected subjects was 8.5 (IQR 3.7–10.3) years and the majority (70%) were girls. Most children (55.2%) had asymptomatic reinfection. Fever was the most common presentation in symptomatic patients. One immunocompromised experienced two reinfection episodes.
Conclusion
SARS-CoV-2 reinfection is uncommon in children. Previous confirmed COVID-19 in children seems to result in a milder reinfection.
Title: Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
Description:
Objective
Subsequent protection from SARS-CoV-2 infection in paediatrics is not well reported in the literature.
We aimed to describe the clinical characteristics and dynamics of SARS-CoV-2 PCR repositivity in children.
Design
This is a population-level retrospective cohort study.
Setting
Patients were identified through multiple national-level electronic COVID-19 databases that cover all primary, secondary and tertiary centres in Kuwait.
Participants
The study included children 12 years and younger between 28 February 2020 and 6 March 2021.
SARS-CoV-2 reinfection was defined as having two or more positive SARS-CoV-2 PCR tests done on a respiratory sample, at least 45 days apart.
Clinical data were obtained from the Pediatric COVID-19 Registry in Kuwait.
Primary and secondary outcome measures
The primary measure is to estimate SARS-CoV-2 PCR repositivity rate.
The secondary objective was to establish average duration between first and subsequent SARS-CoV-2 infection.
Descriptive statistics were used to present clinical data for each infection episode.
Also, incidence-sensitivity analysis was performed to evaluate 60-day and 90-day PCR repositivity intervals.
Results
Thirty paediatric patients with COVID-19 had SARS-CoV-2 reinfection at an incidence of 1.
02 (95% CI 0.
71 to 1.
45) infection per 100 000 person-days and a median time to reinfection of 83 (IQR 62–128.
75) days.
The incidence of reinfection decreased to 0.
78 (95% CI 0.
52 to 1.
17) and 0.
47 (95% CI 0.
28 to 0.
79) per person-day when the minimum interval between PCR repositivity was increased to 60 and 90 days, respectively.
The mean age of reinfected subjects was 8.
5 (IQR 3.
7–10.
3) years and the majority (70%) were girls.
Most children (55.
2%) had asymptomatic reinfection.
Fever was the most common presentation in symptomatic patients.
One immunocompromised experienced two reinfection episodes.
Conclusion
SARS-CoV-2 reinfection is uncommon in children.
Previous confirmed COVID-19 in children seems to result in a milder reinfection.
Related Results
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus , is causing a serious worldwide COVID-19 pandemic. The emergence of strains with rapid spread and...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Proceedings of the Qatar Paediatric Emergency Medicine 2026 Conference - Selected Abstracts
Proceedings of the Qatar Paediatric Emergency Medicine 2026 Conference - Selected Abstracts
Welcome to this issue of Panorama of Emergency Medicine (POEM) dedicated to the 10th Qatar Paediatric Emergency Medicine (Q-PEM) International Conference which was organised and ho...
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology tests
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology tests
Abstract
Background
SARS-CoV-2 serology tests are clinically useful to document a prior SARS-CoV-2 infection in patients with n...
Mutations in SARS-CoV
Mutations in SARS-CoV
The coronavirus family is named for the large spike protein molecules found
on the pathogen exterior, which give the virus a crown-like appearance, the coronavirus
genome is the bi...
Incidence of COVID-19 reinfection among Midwestern healthcare employees
Incidence of COVID-19 reinfection among Midwestern healthcare employees
Abstract
Importance
Given the overwhelming worldwide rate of infection and the disappointing pace of vaccination, addressing re...
Evidence of SARS-CoV-2 reinfection: analysis of 35,000 subjects and overview of systematic reviews
Evidence of SARS-CoV-2 reinfection: analysis of 35,000 subjects and overview of systematic reviews
Abstract
Background: Reinfection by SARS-CoV-2 is a rare but possible event. We evaluated the prevalence of reinfections in the Province of Modena and performed an overview...
Evidence of SARS-CoV-2 Reinfection: Analysis of 35,000 Subjects and Overview of Systematic Reviews
Evidence of SARS-CoV-2 Reinfection: Analysis of 35,000 Subjects and Overview of Systematic Reviews
Background: Reinfection by SARS-CoV-2 is a rare but possible event. We evaluated the prevalence of reinfections in the Province of Modena and performed an overview of systematic re...

